Skip to main content
Log in

Pulmonary toxicity of 5-fluoracil and oxaliplatin

  • Correspondence
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Hernández Yagüe X, Soy E, Queralt Merino B, et al. Interstitial pneumonitis alter oxaliplatin treatment in colorectal cancer. Clin Transl Oncol. 2005;7:515–7.

    Article  Google Scholar 

  2. Frustaci S, Bearz A, Basso B, et al. Efficacy of oxaliplatin and 5-fluoracil in hepatocarcinoma. Proceedings of 39th ASCO meeting 2003, June, Chicago. Chicago: American Society Clinical Oncology; 2003.

    Google Scholar 

  3. Trisolini R, Lazzari Agli L, Tassinari D, et al. Acute lung injury assoicated with 5-fluoracil and oxaliplatinum combined chemotherapy. Eur Resp J, 2001;18:243–5.

    CAS  Google Scholar 

  4. Gagnadoux F, Roiron C, Carrie E, et al. Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer. Am J Clin Oncol. 2002;25(4):588–90.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Ruiz-Casado.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruiz-Casado, A., García, M.D. & Racionero, M.A. Pulmonary toxicity of 5-fluoracil and oxaliplatin. Clin Transl Oncol 8, 624 (2006). https://doi.org/10.1007/s12094-006-0072-2

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-006-0072-2

Keywords

Navigation